Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examination of Programming with the Enterra® Therapy System in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation

NCT06560307 is registered in ClinicalTrials.gov with Enterra Medical, Inc. as lead sponsor.

NCT NCT06560307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06560307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examination of Programming with the Enterra® Therapy System in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation
Lead sponsor
Enterra Medical, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
July 25, 2024
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

gastroparesis, gastroparesis due to diabetes mellitus, gastroparesis nondiabetic